1. Home
  2. LIXT vs HAO Comparison

LIXT vs HAO Comparison

Compare LIXT & HAO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LIXT
  • HAO
  • Stock Information
  • Founded
  • LIXT 2005
  • HAO 2018
  • Country
  • LIXT United States
  • HAO China
  • Employees
  • LIXT N/A
  • HAO N/A
  • Industry
  • LIXT Biotechnology: Pharmaceutical Preparations
  • HAO
  • Sector
  • LIXT Health Care
  • HAO
  • Exchange
  • LIXT Nasdaq
  • HAO NYSE
  • Market Cap
  • LIXT 4.1M
  • HAO 3.3M
  • IPO Year
  • LIXT N/A
  • HAO 2024
  • Fundamental
  • Price
  • LIXT $1.17
  • HAO $1.52
  • Analyst Decision
  • LIXT
  • HAO
  • Analyst Count
  • LIXT 0
  • HAO 0
  • Target Price
  • LIXT N/A
  • HAO N/A
  • AVG Volume (30 Days)
  • LIXT 17.8K
  • HAO 133.5K
  • Earning Date
  • LIXT 05-12-2025
  • HAO 06-09-2025
  • Dividend Yield
  • LIXT N/A
  • HAO N/A
  • EPS Growth
  • LIXT N/A
  • HAO N/A
  • EPS
  • LIXT N/A
  • HAO 0.19
  • Revenue
  • LIXT N/A
  • HAO $48,970,924.00
  • Revenue This Year
  • LIXT N/A
  • HAO N/A
  • Revenue Next Year
  • LIXT N/A
  • HAO N/A
  • P/E Ratio
  • LIXT N/A
  • HAO $7.84
  • Revenue Growth
  • LIXT N/A
  • HAO 15.04
  • 52 Week Low
  • LIXT $1.02
  • HAO $0.84
  • 52 Week High
  • LIXT $3.50
  • HAO $203.00
  • Technical
  • Relative Strength Index (RSI)
  • LIXT 41.14
  • HAO 53.90
  • Support Level
  • LIXT $1.28
  • HAO $0.96
  • Resistance Level
  • LIXT $1.41
  • HAO $2.31
  • Average True Range (ATR)
  • LIXT 0.12
  • HAO 0.30
  • MACD
  • LIXT -0.01
  • HAO -0.00
  • Stochastic Oscillator
  • LIXT 3.23
  • HAO 41.70

About LIXT Lixte Biotechnology Holdings Inc.

Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.

About HAO HAOXI HEALTH TECHNOLOGY LTD

Haoxi Health Technology Ltd is an online marketing solution provider in China, with an advertiser client base mainly in the healthcare industry. Haoxi has been rooted in the field of local online effect marketing for many years, serving customers in various industries at home and abroad, and its main business is the medical industry. It generates its revenue by providing one-stop online marketing solutions, in particular online short video marketing solutions, to advertisers through its media partners. The company provides customized marketing solutions by planning, producing, placing, and optimizing online ads, especially online short video ads, to help its advertisers acquire, convert, and retain ultimate consumers on various online media platforms.

Share on Social Networks: